FALCIANI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 5.125
NA - Nord America 5.079
AS - Asia 835
SA - Sud America 12
OC - Oceania 11
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.078
Nazione #
US - Stati Uniti d'America 5.063
GB - Regno Unito 1.533
IT - Italia 874
IE - Irlanda 860
CN - Cina 593
SE - Svezia 518
UA - Ucraina 439
DE - Germania 294
FR - Francia 220
FI - Finlandia 110
RU - Federazione Russa 101
VN - Vietnam 81
ES - Italia 67
SG - Singapore 54
BE - Belgio 32
IR - Iran 23
PL - Polonia 23
CZ - Repubblica Ceca 18
TR - Turchia 17
IN - India 15
CA - Canada 14
HK - Hong Kong 12
AU - Australia 9
NL - Olanda 8
PK - Pakistan 8
RO - Romania 8
JP - Giappone 7
CI - Costa d'Avorio 6
EU - Europa 6
AT - Austria 5
PE - Perù 5
PH - Filippine 5
BR - Brasile 4
EG - Egitto 4
IL - Israele 4
BD - Bangladesh 3
JO - Giordania 3
RS - Serbia 3
CL - Cile 2
DK - Danimarca 2
EE - Estonia 2
MX - Messico 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
SI - Slovenia 2
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CH - Svizzera 1
EC - Ecuador 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MT - Malta 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 11.078
Città #
Southend 1.452
Dublin 851
Fairfield 661
Chandler 478
Ashburn 419
Siena 381
Jacksonville 360
Woodbridge 339
Ann Arbor 296
Seattle 267
Wilmington 265
Houston 261
Menlo Park 252
Cambridge 206
Beijing 156
Princeton 143
Nanjing 115
Dong Ket 81
Boardman 73
New York 73
Málaga 59
San Mateo 54
Florence 49
Nanchang 48
Shanghai 47
San Diego 45
Helsinki 44
Fremont 40
Dearborn 35
Singapore 35
Brussels 31
Hebei 31
Rome 31
Shenyang 31
Redwood City 28
Moscow 22
Bagno a Ripoli 21
Kunming 21
Tianjin 20
Washington 20
Brno 17
Jiaxing 16
Milan 16
Gdansk 14
London 14
Izmir 13
Ningbo 13
Changsha 12
Chicago 12
Kansas City 12
Phoenix 12
Düsseldorf 11
Toronto 11
Dallas 10
Zhengzhou 10
Norwalk 9
University Park 9
Hangzhou 8
Jinan 8
Taizhou 8
Zanjan 8
Arezzo 7
Colle Di Val D'elsa 7
Guangzhou 7
Lancaster 7
San Francisco 7
Abidjan 6
Atlanta 6
Nürnberg 6
Tappahannock 6
Auburn Hills 5
Campagnano Di Roma 5
Hong Kong 5
Lanzhou 5
Lima 5
Naples 5
Radomsko 5
Venezia 5
Vienna 5
Waukegan 5
Catania 4
Changchun 4
Grosseto 4
Kilburn 4
Leawood 4
Napoli 4
Pontedera 4
Redmond 4
Timisoara 4
Amman 3
Bangalore 3
Barcelona 3
Cairo 3
Canberra 3
Capalbio 3
Castellina In Chianti 3
Como 3
Costa Mesa 3
Fucecchio 3
Fuzhou 3
Totale 8.262
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 261
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 248
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 248
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 243
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions. 213
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 206
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 205
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 201
Tumor imaging with tetrabranched neurotensin 197
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 197
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 191
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 190
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 188
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 183
Branched peptides for tumor diagnosis and therapy 168
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 167
A new NT4 peptide-based drug delivery system for cancer treatment 166
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 165
Branched Neurotensin For Tumor Targeting 162
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 161
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 161
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 156
Branched peptides as bioactive molecules for drug design 156
Synthetic peptides in the form of dendrimers become resistant to protease activity 155
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 154
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 154
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 154
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 152
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 151
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 146
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 143
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 141
Nanoparticles exposing neurotensin tumor-specific drivers. 140
Bioactive peptides from libraries 139
Branched peptides as targeting agents for tumor imaging and therapy 139
Branched multimeric peptides for tumor diagnosis and therapy 138
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 138
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 134
Branched neurotensin for tumor targeting 130
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate. 129
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents. 128
Molecular basis of branched peptides resistance to enzyme proteolysis 127
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 126
Neurotensin-derived branched peptides and uses thereof 122
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 121
BRANCHED PEPTIDES AS THERAPEUTICS 120
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 120
Tumor imaging with tetrabranched neurotensin 120
The development of antimicrobial peptides as new antibacterial drugs. 119
Synthetic antidotes against snake neurotoxins 118
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 118
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles 116
Branched Neurotensin peptides for tumor personalized therapy 115
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 114
The antimicrobial peptide M33. An example of drug development 114
The antimicrobial peptide M33. An example of drug development 112
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 112
Tumor selective targeting by branched peptides 112
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 111
Branched peptides as novel tumor-targeting agents for bladder cancer. 109
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 106
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 105
null 105
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 105
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 103
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 97
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 96
Branched neurotensin peptides for tumor targeting 93
Synthetic peptides in the form of dendrimers can become resistant to protease activity 92
OLIGO-BRANCHED PEPTIDES FOR TUMOR TARGETING: FROM MAGIC BULLETS TO MAGIC FORKS. 88
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 87
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. 86
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 84
Synthetic inhibitors of anthrax lethal toxin 84
NMR and MD studies on the interaction between ligand peptides and alpha-bungarotoxin 84
null 78
Dendrimeric peptides for tumor targeting 71
STRONG SYNTHETIC INHIBITORS OF ANTHRAX LETHAL TOXIN 67
Peptide Drugs 65
Structurally driven selection of human hepatitis C virus mimotopes. 61
Rationally designed affinity maturation of a synthetic antidote against alpha-bungarotoxin 52
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 47
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 45
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 43
The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide 37
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 30
Models of in-vivo Bacterial Infections for the Development of Antimicrobial Peptide-Based Drugs 28
Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer 15
Are periodontitis and psoriasis associated? A pre-clinical murine model 6
Totale 11.284
Categoria #
all - tutte 34.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.746 0 0 149 292 149 158 172 237 182 199 76 132
2020/20212.065 86 157 41 166 71 279 211 273 176 286 131 188
2021/20221.253 80 125 78 137 84 50 53 78 45 152 125 246
2022/20231.756 94 182 214 227 186 336 41 142 145 81 76 32
2023/20241.387 44 43 123 80 60 390 481 29 7 27 15 88
2024/2025181 54 127 0 0 0 0 0 0 0 0 0 0
Totale 11.284